Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension
NCT00332384Phase 3Completed
- Sponsor
- Allergan
- Start
- Jan 2000
- Primary completion
- Nov 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine, timolol in Glaucoma, ocular hypertension, sponsored by Allergan. Started Jan 2000; status: completed.
02
Drugs
brimonidinetimolol
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00332384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332384.